R S De Pablo-Bernal1, E Ruiz-Mateos1, I Rosado1, B Dominguez-Molina1, A I Alvarez-Ríos2, A Carrillo-Vico3, R De La Rosa4, J Delgado5, M A Muñoz-Fernández5, M Leal6, S Ferrando-Martínez5. 1. Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain. 2. Department of Clinical Biochemistry, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital IBiS/CSIC/University of Seville, Seville, Spain. 3. Department of Medical Biochemistry and Molecular Biology and Immunology, University of Seville School of Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital/CSIC/University of Seville and Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF)-Instituto de Salud Carlos III, Seville, Spain. 4. Internal Medicine Service, San Juan de Dios Hospital, Bormujos, Seville, Spain. 5. Laboratory of Molecular Immuno-Biology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 6. Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain mleal@telefonica.net.
Abstract
BACKGROUND: Chronic and systemic inflammatory alterations occur in HIV-infected patients and elderly uninfected subjects and in both scenarios these alterations are associated with the development of chronic morbidities and mortality. However, whether the levels of inflammatory alterations in untreated HIV-infected patients and elderly individuals are similar is unknown. Moreover, whether long-term antiretroviral therapy normalizes inflammatory alterations compared with HIV-uninfected persons of different age is not known. METHODS: We analysed soluble inflammatory levels [high-sensitivity C-reactive protein, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8 and IL-17] in a cohort of viraemic HIV-infected patients compared with (i) age-matched, (ii) elderly and (iii) non-survivor elderly, uninfected healthy controls. We longitudinally analysed the effect of long-term 48 and 96 week suppressive combined antiretroviral therapy (cART) on the soluble inflammatory levels compared with those found in control subjects. RESULTS: Baseline IL-6 and IL-8 levels were at similar or lower concentrations in untreated patients compared with healthy elderly individuals. However, TNF-α and IFN-γ levels broadly exceeded those found in survivors and non-survivor elderly individuals. Long-term suppressive cART normalized most of the inflammatory markers, with the exception of TNF-α levels, which persisted as high as those in elderly non-survivor controls. CONCLUSIONS: Chronic inflammatory alterations associated with HIV infection are maintained at a different level from those of ageing. The persistent alteration of TNF-α levels in HIV-infected patients might cause tissue damage and have implications for developing non-AIDS-defining illnesses, even when HIV replication is long-term controlled by cART.
BACKGROUND: Chronic and systemic inflammatory alterations occur in HIV-infectedpatients and elderly uninfected subjects and in both scenarios these alterations are associated with the development of chronic morbidities and mortality. However, whether the levels of inflammatory alterations in untreated HIV-infectedpatients and elderly individuals are similar is unknown. Moreover, whether long-term antiretroviral therapy normalizes inflammatory alterations compared with HIV-uninfectedpersons of different age is not known. METHODS: We analysed soluble inflammatory levels [high-sensitivity C-reactive protein, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8 and IL-17] in a cohort of viraemic HIV-infectedpatients compared with (i) age-matched, (ii) elderly and (iii) non-survivor elderly, uninfected healthy controls. We longitudinally analysed the effect of long-term 48 and 96 week suppressive combined antiretroviral therapy (cART) on the soluble inflammatory levels compared with those found in control subjects. RESULTS: Baseline IL-6 and IL-8 levels were at similar or lower concentrations in untreated patients compared with healthy elderly individuals. However, TNF-α and IFN-γ levels broadly exceeded those found in survivors and non-survivor elderly individuals. Long-term suppressive cART normalized most of the inflammatory markers, with the exception of TNF-α levels, which persisted as high as those in elderly non-survivor controls. CONCLUSIONS: Chronic inflammatory alterations associated with HIV infection are maintained at a different level from those of ageing. The persistent alteration of TNF-α levels in HIV-infectedpatients might cause tissue damage and have implications for developing non-AIDS-defining illnesses, even when HIV replication is long-term controlled by cART.
Authors: Corrilynn O Hileman; Bruce Kinley; Valeska Scharen-Guivel; Kathy Melbourne; Javier Szwarcberg; Janet Robinson; Michael M Lederman; Grace A Mccomsey Journal: J Infect Dis Date: 2015-01-12 Impact factor: 5.226
Authors: Vidya Mave; Kristine M Erlandson; Nikhil Gupte; Ashwin Balagopal; David M Asmuth; Thomas B Campbell; Laura Smeaton; Nagalingeswaran Kumarasamy; James Hakim; Breno Santos; Cynthia Riviere; Mina C Hosseinipour; Patcharaphan Sugandhavesa; Rosa Infante; Sandy Pillay; Sandra W Cardoso; Srikanth Tripathy; Noluthando Mwelase; Sima Berendes; Bruno B Andrade; David L Thomas; Robert C Bollinger; Amita Gupta Journal: J Infect Dis Date: 2016-03-08 Impact factor: 5.226
Authors: Marc Beyer; Zeinab Abdullah; Jens M Chemnitz; Daniela Maisel; Jil Sander; Clara Lehmann; Yasser Thabet; Prashant V Shinde; Lisa Schmidleithner; Maren Köhne; Jonel Trebicka; Robert Schierwagen; Andrea Hofmann; Alexey Popov; Karl S Lang; Annette Oxenius; Thorsten Buch; Christian Kurts; Mathias Heikenwalder; Gerd Fätkenheuer; Philipp A Lang; Pia Hartmann; Percy A Knolle; Joachim L Schultze Journal: Nat Immunol Date: 2016-03-07 Impact factor: 25.606
Authors: Rebeca Sara de Pablo-Bernal; Julio Cañizares; Isaac Rosado; María Isabel Galvá; Ana Isabel Alvarez-Ríos; Antonio Carrillo-Vico; Sara Ferrando-Martínez; María Ángeles Muñoz-Fernández; Mohammed Rafii-El-Idrissi Benhnia; Yolanda María Pacheco; Raquel Ramos; Manuel Leal; Ezequiel Ruiz-Mateos Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-18 Impact factor: 6.053
Authors: Sara H Bares; Laura M Smeaton; Sarah E Scott; Beth A Smith; Catherine Godfrey; Grace A McComsey Journal: J Infect Dis Date: 2021-11-22 Impact factor: 7.759
Authors: Boghuma K Titanji; Mehul Tejani; Eugene W Farber; C Christina Mehta; Thaddeus W Pace; Kathryn Meagley; Christina Gavegnano; Timothy Harrison; Caroline W Kokubun; Satya Dev Negi; Raymond F Schinazi; Vincent C Marconi Journal: J Acquir Immune Defic Syndr Date: 2022-03-01 Impact factor: 3.771